All CSF markers measured were higher in participants with AD compared to CN participants, with group differences in SNAP25Total, SNAP25Long, neurogranin, and GAP‐43 achieving significance (Figure 3, eTable 5). This evidence concerns the gene NRGN and Alzheimer disease.